PLEKHA4 expression was associated with age (P < 0.001), WHO grade (P < 0.001), IDH mutation status (P < 0.001), 1p19q codeletion status (P < 0.001), and histological type (P < 0.001) in glioma patients. This evidence concerns the gene PLEKHA4 and central nervous system cancer.